Understanding the Atrial Fibrillation Classification System

Atrial fibrillation is not the most common of the cardiac arrhythmias, but it is the most common arrhythmia that that can produce dire consequences. But not all atrial fibrillation is the same. Sometimes the risk posed by atrial fibrillation is substantial; in other cases, the risk is not as high.

Doctor checking patient's heart with stethoscope at a hospital

Anchalee Phanmaha / Getty Images

So, in an effort to categorize the degree of risk posed by atrial fibrillation in individual patients, healthcare providers over the years have devised several different classification systems to describe the various “types” of atrial fibrillation. These different classification schemes, all devised with noble intent, have resulted in a lot of confusing terminology that, for many practitioners, failed to clarify the issue, and in fact had the opposite effect.

In an effort to put healthcare providers all on the same page in regard to atrial fibrillation, in 2014 a general classification system was established by the American Heart Association, the American College of Cardiology, and the Heart Rhythm Society. This classification system is aimed at helping practitioners decide how to evaluate patients with atrial fibrillation, and how best to treat them. It is the classification system that now should supplant all the older ones.

The new classification recognizes that atrial fibrillation is most often a progressive condition. At first, the arrhythmia usually occurs in episodes that are intermittent and brief. As time goes by, the episodes tend to become more frequent and longer-lasting. Eventually, in many patients, atrial fibrillation entirely supplants the normal heart rhythm and becomes permanent.

The “type” of atrial fibrillation that is seen when a person is first diagnosed with this arrhythmia can help the healthcare provider make recommendations about the most appropriate approach to therapy. The more a patient’s arrhythmia has progressed toward permanent atrial fibrillation, for instance, the less likely it is that a normal heart rhythm can be restored and maintained.

The Atrial Fibrillation Classification System

Here is the current standardized system of classifying atrial fibrillation.

Paroxysmal Atrial Fibrillation

Atrial fibrillation is said to be paroxysmal (a medical term for “intermittent”) if it occurs in discrete episodes less than seven days in duration. In many cases, paroxysmal atrial fibrillation may last for only minutes to hours. Episodes of paroxysmal atrial fibrillation can be very frequent, or quite rare.

Some patients with paroxysmal atrial fibrillation will have brief episodes that produce no symptoms and are entirely “subclinical.” This means that neither the patient nor their healthcare provider is aware that episodes of atrial fibrillation are occurring. In these cases, the arrhythmia is usually discovered unexpectedly during cardiac monitoring. Subclinical atrial fibrillation is important because it, like more severe cases of atrial fibrillation, can lead to stroke.

It is these subclinical episodes of atrial fibrillation that consumer products like the Apple Watch and the AliveCor device are meant to detect. Early detection of paroxysmal atrial fibrillation can allow for preventive treatment to reduce the risk of stroke.

Persistent Atrial Fibrillation

In this second category, the atrial fibrillation occurs in episodes that fail to terminate within seven days. That is, in distinction to paroxysmal atrial fibrillation, persistent atrial fibrillation tends to last a long time. In fact, in order to restore a normal heart rhythm, medical intervention is most often necessary.

Patients who have one or more episodes of persistent atrial fibrillation may at other times still have episodes of paroxysmal atrial fibrillation, but they are now classified as having a “persistent” arrhythmia. When treating a person with persistent atrial fibrillation, cardiac electrophysiologists tend to aim their treatment at getting rid of the atrial fibrillation and restoring a normal cardiac rhythm.

Long-standing Persistent Atrial Fibrillation

In these patients, an episode of atrial fibrillation is known to have lasted longer than 12 months. For all practical purposes, atrial fibrillation has become the new, “baseline” cardiac rhythm in these patients. While efforts to restore a normal heart rhythm may still be attempted, those efforts are less likely to be effective.

Permanent Atrial Fibrillation

The only difference between “long-standing persistent” and “permanent” atrial fibrillation is that with permanent atrial fibrillation, the healthcare provider and patient have agreed to abandon further efforts to restore normal heart rhythm and have moved on to a different treatment strategy. They have declared the atrial fibrillation to be permanent, and have adopted a rate-control strategy of therapy.

Valvular and Non-Valvular Atrial Fibrillation

A different classification for atrial fibrillation that you will commonly hear about is valvular atrial fibrillation versus non-valvular atrial fibrillation; that is, whether or not the atrial fibrillation is associated with valvular heart disease, such as mitral stenosis.

For practical purposes, this classification is taken into account only when deciding on anticoagulation therapy to prevent stroke. Essentially, patients with valvular atrial fibrillation virtually always need anticoagulation; patients with non-valvular atrial fibrillation may not.

A Word From Verywell

The chief benefit of this classification system for atrial fibrillation is that it standardizes the nomenclature, so that when healthcare providers talk to each other about atrial fibrillation, they all mean the same thing. It helps you, too, to understand your condition.

In addition, it gives practitioners some idea about how far a patient’s atrial fibrillation has progressed toward becoming a permanent heart rhythm, and thus, how likely it is that a strategy aimed at restoring a normal rhythm might be effective. Ultimately, it’ll help you and your medical professional make a treatment decision that’s best for you.

13 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Centers for Disease Control and Prevention. Atrial fibrillation.

  2. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the american college of cardiology/american heart association task force on practice guidelines and the heart rhythm societyCirculation. 2014;130(23). doi:10.1161/CIR.0000000000000041

  3. Curtis A, Shukla A. Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progressionVHRM. 2013;2014(10):1-12. doi:10.2147/VHRM.S49334

  4. Cedars-Sinai. Atrial fibrillation.

  5. Ogawa H, An Y, Ikeda S, et al. Progression from paroxysmal to sustained atrial fibrillation is associated with increased adverse eventsStroke. 2018;49(10):2301-2308. doi:10.1161/STROKEAHA.118.021396

  6. University of Michigan Health. Atrial fibrillation - afib.

  7. Patti G, Sticchi A. Subclinical atrial fibrillation: when to give NAOEuropean Heart Journal Supplements. 2020;22(Supplement_E):E105-E109. doi:10.1093/eurheartj/suaa072

  8. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of strokeN Engl J Med. 2012;366(2):120-129. doi:10.1056/NEJMoa1105575

  9. Noseworthy PA, Kaufman ES, Chen LY, et al. Subclinical and device-detected atrial fibrillation: pondering the knowledge gap: a scientific statement from the american heart associationCirculation. 2019;140(25). doi:10.1161/CIR.0000000000000740

  10. Johns Hopkins Medicine. What Is afib?

  11. Mody BP, Raza A, Jacobson J, et al. Ablation of long-standing persistent atrial fibrillationAnn Transl Med. 2017;5(15):305-305. doi:10.21037/atm.2017.05.21

  12. Fauchier L, Philippart R, Clementy N, et al. How to define valvular atrial fibrillation? Archives of Cardiovascular Diseases. 2015;108(10):530-539. doi: 10.1016/j.acvd.2015.06.002

  13. Koci F, Forbes P, Mansour MC, et al. New classification scheme for atrial fibrillation symptom severity and burdenThe American Journal of Cardiology. 2014;114(2):260-265. doi:10.1016/j.amjcard.2014.04.032

Additional Reading
  • January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130:e199.

By Richard N. Fogoros, MD
Richard N. Fogoros, MD, is a retired professor of medicine and board-certified in internal medicine, clinical cardiology, and clinical electrophysiology.